Commonwealth Equity Services, LLC Reata Pharmaceuticals Inc Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 11, 2020
SELL
$124.16 - $247.74 $126,270 - $251,951
-1,017 Closed
0 $0
Q4 2019

Feb 05, 2020
BUY
$74.57 - $217.92 $75,837 - $221,624
1,017 New
1,017 $207,000
Q3 2019

Oct 30, 2019
SELL
$71.26 - $95.75 $173,304 - $232,864
-2,432 Closed
0 $0
Q2 2019

Jul 19, 2019
BUY
$77.72 - $94.35 $189,015 - $229,459
2,432 New
2,432 $229,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email